A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgia.

Journal of opioid management

Volumn 2, Issue 3, 2006, Pages 167-173

  Wallace, Mark S ^a   Moulin, Dwight ^a   Clark, A J ^a   Wasserman, Ronald ^a   Neale, Ann ^a   Morley Forster, Patricia ^a   Castaigne, Jean Paul ^a   Teichman, Sam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNORPHIN; DYNORPHIN (1 13); DYNORPHIN (1-13); NARCOTIC ANALGESIC AGENT; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DYNORPHINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PEPTIDE FRAGMENTS; TIME FACTORS;

MLCS; MLOWN;

EID: 34047215357     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2006.0026     Document Type: Article

References (0)